245 related articles for article (PubMed ID: 31862674)
21. The TIGIT/CD226 axis regulates human T cell function.
Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
[TBL] [Abstract][Full Text] [Related]
22. Phenotype and Function of Myeloid-Derived Suppressor Cells Induced by Porphyromonas gingivalis Infection.
Su L; Xu Q; Zhang P; Michalek SM; Katz J
Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28533469
[No Abstract] [Full Text] [Related]
23. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.
Varga G; Ehrchen J; Tsianakas A; Tenbrock K; Rattenholl A; Seeliger S; Mack M; Roth J; Sunderkoetter C
J Leukoc Biol; 2008 Sep; 84(3):644-50. PubMed ID: 18611985
[TBL] [Abstract][Full Text] [Related]
24. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.
Zhang S; Yong LK; Li D; Cubas R; Chen C; Yao Q
PLoS One; 2013; 8(7):e68303. PubMed ID: 23874581
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
26. T cells Exhibit Reduced Signal Transducer and Activator of Transcription 5 Phosphorylation and Upregulated Coinhibitory Molecule Expression After Kidney Transplantation.
Bouvy AP; Klepper M; Kho MM; Ijzermans JN; Betjes MG; Weimar W; Baan CC
Transplantation; 2015 Sep; 99(9):1995-2003. PubMed ID: 25769075
[TBL] [Abstract][Full Text] [Related]
27. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
[No Abstract] [Full Text] [Related]
28. TOX-expressing terminally exhausted tumor-infiltrating CD8
Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
[TBL] [Abstract][Full Text] [Related]
29. TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.
Chew GM; Fujita T; Webb GM; Burwitz BJ; Wu HL; Reed JS; Hammond KB; Clayton KL; Ishii N; Abdel-Mohsen M; Liegler T; Mitchell BI; Hecht FM; Ostrowski M; Shikuma CM; Hansen SG; Maurer M; Korman AJ; Deeks SG; Sacha JB; Ndhlovu LC
PLoS Pathog; 2016 Jan; 12(1):e1005349. PubMed ID: 26741490
[TBL] [Abstract][Full Text] [Related]
30. Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade.
Lin C; Ren W; Luo Y; Li S; Chang Y; Li L; Xiong D; Huang X; Xu Z; Yu Z; Wang Y; Zhang J; Huang C; Xia N
Cancer Immunol Res; 2020 May; 8(5):632-647. PubMed ID: 32127389
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model.
Ma H; Wan S; Xia CQ
J Leukoc Biol; 2016 Jun; 99(6):1121-9. PubMed ID: 26657791
[TBL] [Abstract][Full Text] [Related]
32. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
Chauvin JM; Pagliano O; Fourcade J; Sun Z; Wang H; Sander C; Kirkwood JM; Chen TH; Maurer M; Korman AJ; Zarour HM
J Clin Invest; 2015 May; 125(5):2046-58. PubMed ID: 25866972
[TBL] [Abstract][Full Text] [Related]
33. CD155-Transducing Signaling through TIGIT Plays an Important Role in Transmission of Tolerant State and Suppression Capacity.
Negishi N; Sato T; Yamashita-Kanemaru Y; Shibuya K; Uchida K; Kametani Y; Yagita H; Kitaura J; Okumura K; Habu S
Immunohorizons; 2018 Nov; 2(10):338-348. PubMed ID: 31022697
[TBL] [Abstract][Full Text] [Related]
34. Chemoresistance in mesenchymal lung cancer cells is correlated to high regulatory T cell presence in the tumor microenvironment.
Zhang LN; Xin T; Chen M; Gao P
IUBMB Life; 2019 Jul; 71(7):986-991. PubMed ID: 31066485
[TBL] [Abstract][Full Text] [Related]
35. CD160 expression on CD8
Liu S; Zhang W; Liu K; Wang Y
Cancer Immunol Immunother; 2020 May; 69(5):789-797. PubMed ID: 32055919
[TBL] [Abstract][Full Text] [Related]
36. Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.
Sarhan D; Cichocki F; Zhang B; Yingst A; Spellman SR; Cooley S; Verneris MR; Blazar BR; Miller JS
Cancer Res; 2016 Oct; 76(19):5696-5706. PubMed ID: 27503932
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
[TBL] [Abstract][Full Text] [Related]
38. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
[TBL] [Abstract][Full Text] [Related]
39. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
[TBL] [Abstract][Full Text] [Related]
40. Plasmacytoid dendritic cells play a key role in tumor progression in lipopolysaccharide-stimulated lung tumor-bearing mice.
Rega A; Terlizzi M; Luciano A; Forte G; Crother TR; Arra C; Arditi M; Pinto A; Sorrentino R
J Immunol; 2013 Mar; 190(5):2391-402. PubMed ID: 23355734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
